live vaccinia virus vaccine
Vaccineexperimental
Clinical trial activity
4 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
3
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started Oct 1, 2002 (NCT00050505)
Timeline
Indications
Mechanism of action
- Vaccinia virusImmunity, active
Vaccinia virus immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- live vaccinia virus vaccine
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT03953196 | Early Phase 1 (Phase 1) | Apr 8, 2019 | Johnson and Johnson |
| NCT00133575 | Phase 1/Phase 2 (Phase 2) | Oct 1, 2005 | National Institute of Allergy and Infectious Diseases (NIAID) |
| NCT00082446 | Phase 1 | May 1, 2004 | National Institute of Allergy and Infectious Diseases (NIAID) |
| NCT00050505 | Phase 2 | Oct 1, 2002 | National Institute of Allergy and Infectious Diseases (NIAID) |
Showing 4 of 4 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| National Institute of Allergy and Infectious Diseases (NIAID) | Government | 3 | 3 | 2 | 2002 |
| Johnson and Johnson | For profit | 1 | 1 | 1 | 2019 |
2 organizations
Page 1 / 1